BSE Live
Jan 16, 16:01Prev. Close
802.75
Open Price
822.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 16, 15:59Prev. Close
803.15
Open Price
803.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
790.05 (1319)
| Key Financial Ratios of Senores Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 1.02 | 0.35 | 1.26 | 0.53 | 4.07 | |
| Diluted EPS (Rs.) | 1.02 | 0.32 | 0.95 | 0.53 | 4.07 | |
| Cash EPS (Rs.) | 1.47 | 0.93 | 2.17 | 1.00 | 3.69 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 153.74 | 55.11 | 39.65 | 38.60 | 24.91 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 153.74 | 55.11 | 39.65 | 38.60 | 24.91 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 8.37 | 11.15 | 12.61 | 18.13 | 20.81 | |
| PBDIT/Share (Rs.) | 3.19 | 2.22 | 5.10 | 2.26 | 3.07 | |
| PBIT/Share (Rs.) | 2.53 | 1.56 | 4.16 | 1.60 | 1.58 | |
| PBT/Share (Rs.) | 1.11 | 0.67 | 1.98 | 1.04 | 1.05 | |
| Net Profit/Share (Rs.) | 0.80 | 0.27 | 1.22 | 0.34 | 2.20 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 38.16 | 19.95 | 40.47 | 12.45 | 14.73 | |
| PBIT Margin (%) | 30.17 | 13.95 | 32.95 | 8.81 | 7.58 | |
| PBT Margin (%) | 13.25 | 5.98 | 15.67 | 5.70 | 5.05 | |
| Net Profit Margin (%) | 9.57 | 2.39 | 9.68 | 1.84 | 10.57 | |
| Return on Networth / Equity (%) | 0.52 | 0.48 | 3.08 | 0.86 | 8.83 | |
| Return on Capital Employed (%) | 1.46 | 2.43 | 6.28 | 3.89 | 4.73 | |
| Return on Assets (%) | 0.44 | 0.28 | 1.07 | 0.53 | 5.58 | |
| Total Debt/Equity (X) | 0.13 | 0.55 | 1.55 | 0.43 | 0.39 | |
| Asset Turnover Ratio (%) | 0.07 | 0.17 | 0.15 | 0.46 | 0.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 9.99 | 0.44 | 0.59 | 0.81 | 3.58 | |
| Quick Ratio (X) | 9.78 | 0.39 | 0.52 | 0.78 | 3.43 | |
| Inventory Turnover Ratio (X) | 5.85 | 8.90 | 0.19 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 2,371.76 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 61.54 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 161.23 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 68.44 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 3.73 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 68.44 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
16.12.2025
12.11.2025
Senores Pharma Standalone September 2025 Net Sales at Rs 35.33 crore, up 266.87% Y-o-Y
07.11.2025
Senores Pharma Consolidated September 2025 Net Sales at Rs 161.76 crore, down 10.24% Y-o-Y
24.07.2025
Senores Pharma Standalone June 2025 Net Sales at Rs 19.82 crore, up 164.97% Y-o-Y
12.11.2025
Senores Pharma Standalone September 2025 Net Sales at Rs 35.33 crore, up 266.87% Y-o-Y
07.11.2025
Senores Pharma Consolidated September 2025 Net Sales at Rs 161.76 crore, down 10.24% Y-o-Y
24.07.2025
Senores Pharma Standalone June 2025 Net Sales at Rs 19.82 crore, up 164.97% Y-o-Y
16.05.2025
Senores Pharma Consolidated March 2025 Net Sales at Rs 114.21 crore, up 11.5% YoY